Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability offerings, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced financial results for the fourth quarter and full-year 2025.

Braze (Nasdaq: BRZE), the leading customer engagement platform that empowers brands to Be Absolutely Engaging™, today announced results for its fiscal year ended January 31, 2026.

Successfully dosed first three cohorts in SAD portion of ongoing ABS-201™ HEADLINE trial; well-tolerated with favorable emerging safety data Unveiled human ex vivo data demonstrating that ABS-201 stimulates hair growth and regenerates follicle stem cell niche Appointed seasoned biopharmaceutical executive Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer Cash, cash equivalents, and marketable securities sufficient to fund operations into the first half of 2028 VANCOUVER, Wash. and NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today reported financial ...

EyeFitU's Approximately $440,000 in Annual Recurring Revenue Expected to Be Accretive to Naiz Fit, with Potential to GrowMySize's Four-Part Platform Helps Brands Cut Returns, Sell More Inventory, and Expand Distribution; EyeFitU Assets Expected to Strengthen the Naiz Fit Sizing EngineAIRPORT CITY, Israel, March 23, 2026 /PRNewswire/ -- MySize, Inc. (Nasdaq: MYSZ) ("MySize" or the "Company") today announced that its subsidiary Naiz Fit has signed a non-binding Letter of Intent (LOI) to acquire selected assets of EyeFitU AG, a Switzerland-based provider of digital sizing and fit technology for fashion brands and retailers.